Ccme Global Ltd vs Nephrocare Health Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of CCME Global Ltd is ₹ 30.22 as of 23 Oct 15:30 . The P/E Ratio of CCME Global Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Nephrocare Health Services Ltd changed from 66 on March 2026 to 66 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of CCME Global Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Nephrocare Health Services Ltd changed from ₹ 5072 crore on March 2026 to ₹ 5072 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of CCME Global Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Nephrocare Health Services Ltd for the Jun '26 is ₹ 289.21 crore as compare to the Mar '26 revenue of ₹ 277.18 crore. This represent the growth of 4.34% The ebitda of CCME Global Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Nephrocare Health Services Ltd for the Jun '26 is ₹ 67.78 crore as compare to the Mar '26 ebitda of ₹ 62.24 crore. This represent the growth of 8.9% The net profit of CCME Global Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Nephrocare Health Services Ltd changed from ₹ 20.11 crore to ₹ 31.97 crore over 7 quarters. This represents a CAGR of 30.33% The Dividend Payout of CCME Global Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Nephrocare Health Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About CCME Global Ltd

Genesis IBRC India Limited was formerly incorporated as Fine Plast Polymers Limited in October, 1992.
Thereafter, the name of the Company was changed from Fine Plast Polymers Limited to SSK Lifestyles Limited in October, 2014 and further was changed from SSK Lifestyles Limited to Genesis IBRC India Limited in January, 2018.
Promoted by P M Rao, P Janardhana Rao, P Rama Rao and their Associates, the Company came out with a public issue in Dec.'93 to part-finance the setting up of its plant in Pamur, Andhra Pradesh.
The plant has an installed capacity of 432 tpa for rigid PVC pipes and 778 tpa for PVC fittings. Initially, Company manufactured rigid PVC pipes and fittings like tees, elbows, adopters, reducers, end caps, etc. used in agriculture and agro-based activities like sprinkler irrigation systems, process piping, oil and gas and shipping industries.

About Nephrocare Health Services Ltd

Nephrocare Health Services Limited was incorporated as 'Nephrocare Health Services Private Limited', a private limited company at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh on December 18, 2009.
Company was converted into a public limited company and the name was changed to 'Nephrocare Health Services Limited' with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre. Company offer comprehensive dialysis care through a network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy.
The Company began journey in 2010 with the launch of its first dialysis clinic in Hyderabad.
It launched first Public Private Partnership (PPP) clinic in Sananth Nagar, Hyderabad in 2012; acquired 100% stake in DaVita Care (India) Private Limited, the Indian arm of DaVita Care Pte Ltd.

FAQs for the comparison of CCME Global Ltd and Nephrocare Health Services Ltd

Which company has a larger market capitalization, CCME Global Ltd or Nephrocare Health Services Ltd?

Market cap of CCME Global Ltd is 136 Cr while Market cap of Nephrocare Health Services Ltd is 6,006 Cr

What are the key factors driving the stock performance of CCME Global Ltd and Nephrocare Health Services Ltd?

The stock performance of CCME Global Ltd and Nephrocare Health Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for CCME Global Ltd and Nephrocare Health Services Ltd?

As of October 25, 2026, the CCME Global Ltd stock price is INR ₹30.22. On the other hand, Nephrocare Health Services Ltd stock price is INR ₹597.3.

How do dividend payouts of CCME Global Ltd and Nephrocare Health Services Ltd compare?

To compare the dividend payouts of CCME Global Ltd and Nephrocare Health Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.